Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AOP Orphan Pharmaceuticals AG, against the decision of the State Institute for Drug Control from 21. 9. 2020, under the no. SUKLS162143/2020:

• the appeals are dismissed as inadmissible.
  

More information: MZCR.cz.

Published 18. 11. 2020.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Teva Pharmaceuticals CR, s.r.o. and Teva Pharmaceutical Industries Ltd., against the decision of the State Institute for Drug Control from 15. 2. 2019, sp. zn. SUKLS13312/2019:

• the appeals are dismissed as inadmissible.
  

More information: MZCR.cz.

Published 12. 11. 2020.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant BERLIN-CHEMIE AG, against the decision of the State Institute for Drug Control from 7. 8. 2020 under the no. SUKLS176540/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Published 11. 11. 2020.

Notification of the Ministry of Health of the Czech Republic, against the decision of the State Institute for Drug Control from 13. 11.2019 under the no SUKLS191125/2019, regarding the withdrawal of the appeal of the appelant Amgen Europe B.V. The decision of the State Institute for Drug Control is valid since 16. 5. 2020.

More information: MZCR.cz.

Published 20. 10. 2020.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Novartis Europharm Limited, against the decision of the State Institute for Drug Control from 30. 7. 2020, under the no. SUKLS186193/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Published 20. 10. 2020.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant B. Braun Melsungen AG, against the decision of the State Institute for Drug Control from 4. 7. 2018, under the no. SUKLS380918/2017:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Published 15. 10. 2020.

Key information for patients, consumers and healthcare professionals published monthly by the European Medicines Agency.

Notification of the Ministry of Health of the Czech Republic against the decision of the State Institute for Drug Control from 23. 12. 2019, under the no. SUKLS52336/2019, regarding the withdrawal of the appeal  of the appelant Alexion Europe SAS. The decision of the State Institute for Drug Control is valide since 30. 9. 2020.